APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma-derived Factor VIII

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasma-derived Factor VIII Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchPlasma-derived Factor VIII Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma-derived Factor VIII Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Plasma-derived Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma-derived Factor VIII Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma-derived Factor VIII Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Plasma-derived Factor VIII market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasma-derived Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasma-derived Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma-derived Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasma-derived Factor VIII include Takeda, RAAS, Hualan Bio, Octapharma, Kedrion, Grifols, Greencross, CSL and BPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasma-derived Factor VIII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasma-derived Factor VIII market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma-derived Factor VIII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma-derived Factor VIII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Plasma-derived Factor VIII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasma-derived Factor VIII Market by Company

Takeda

RAAS

Hualan Bio

Octapharma

Kedrion

Grifols

Greencross

CSL

BPL

Plasma-derived Factor VIII Segment by Type

200IU

250IU

Plasma-derived Factor VIII Segment by Application

Hospital

Pharmacy

Plasma-derived Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma-derived Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma-derived Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma-derived Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma-derived Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Plasma-derived Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200IU Table 2. Major Company of 250IU Table 3. Global Plasma-derived Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 5. Global Plasma-derived Factor VIII Sales Market Share in Volume by Type (2021-2026) Table 6. Global Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 7. Global Plasma-derived Factor VIII Sales Market Share in Value by Type (2021-2026) Table 8. Global Plasma-derived Factor VIII Price by Type (2021-2026) & (US$/unit) Table 9. Global Plasma-derived Factor VIII Sales by Type (2027-2032) & (units) Table 10. Global Plasma-derived Factor VIII Sales Market Share in Volume by Type (2027-2032) Table 11. Global Plasma-derived Factor VIII Sales by Type (2027-2032) & (US$ Million) Table 12. Global Plasma-derived Factor VIII Sales Market Share in Value by Type (2027-2032) Table 13. Global Plasma-derived Factor VIII Price by Type (2027-2032) & (US$/unit) Table 14. North America Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 15. North America Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 17. Europe Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 21. Latin America Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Plasma-derived Factor VIII Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Plasma-derived Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 24. Plasma-derived Factor VIII Industry Trends Table 25. Plasma-derived Factor VIII Industry Drivers Table 26. Plasma-derived Factor VIII Industry Opportunities and Challenges Table 27. Plasma-derived Factor VIII Industry Restraints Table 28. Global Plasma-derived Factor VIII Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Plasma-derived Factor VIII Revenue Market Share by Company (2021-2026) Table 30. Global Plasma-derived Factor VIII Sales by Company (2021-2026) & (units) Table 31. Global Plasma-derived Factor VIII Sales Share by Company (2021-2026) Table 32. Global Plasma-derived Factor VIII Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Plasma-derived Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Plasma-derived Factor VIII Major Company Production Sites and Headquarters Table 35. Global Plasma-derived Factor VIII Company, Product Type & Application Table 36. Global Plasma-derived Factor VIII Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Plasma-derived Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Plasma-derived Factor VIII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Plasma-derived Factor VIII Sales by Region (2021-2026) & (units) Table 41. Global Plasma-derived Factor VIII Sales Market Share in Volume by Region (2021-2026) Table 42. Global Plasma-derived Factor VIII Sales by Region (2021-2026) & (US$ Million) Table 43. Global Plasma-derived Factor VIII Sales Market Share in Value by Region (2021-2026) Table 44. Global Plasma-derived Factor VIII Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Plasma-derived Factor VIII Sales by Region (2027-2032) & (units) Table 46. Global Plasma-derived Factor VIII Sales Market Share in Volume by Region (2027-2032) Table 47. Global Plasma-derived Factor VIII Sales by Region (2027-2032) & (US$ Million) Table 48. Global Plasma-derived Factor VIII Sales Market Share in Value by Region (2027-2032) Table 49. Global Plasma-derived Factor VIII Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Plasma-derived Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 52. Global Plasma-derived Factor VIII Sales Market Share in Volume by Application (2021-2026) Table 53. Global Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 54. Global Plasma-derived Factor VIII Sales Market Share in Value by Application (2021-2026) Table 55. Global Plasma-derived Factor VIII Price by Application (2021-2026) & (US$/unit) Table 56. Global Plasma-derived Factor VIII Sales by Application (2027-2032) & (units) Table 57. Global Plasma-derived Factor VIII Sales Market Share in Volume by Application (2027-2032) Table 58. Global Plasma-derived Factor VIII Sales by Application (2027-2032) & (US$ Million) Table 59. Global Plasma-derived Factor VIII Sales Market Share in Value by Application (2027-2032) Table 60. Global Plasma-derived Factor VIII Price by Application (2027-2032) & (US$/unit) Table 61. North America Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 62. North America Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 64. Europe Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 68. Latin America Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Plasma-derived Factor VIII Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Plasma-derived Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Plasma-derived Factor VIII Product Portfolio Table 75. Takeda Recent Development Table 76. RAAS Company Information Table 77. RAAS Business Overview Table 78. RAAS Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. RAAS Plasma-derived Factor VIII Product Portfolio Table 80. RAAS Recent Development Table 81. Hualan Bio Company Information Table 82. Hualan Bio Business Overview Table 83. Hualan Bio Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Hualan Bio Plasma-derived Factor VIII Product Portfolio Table 85. Hualan Bio Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Octapharma Plasma-derived Factor VIII Product Portfolio Table 90. Octapharma Recent Development Table 91. Kedrion Company Information Table 92. Kedrion Business Overview Table 93. Kedrion Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Kedrion Plasma-derived Factor VIII Product Portfolio Table 95. Kedrion Recent Development Table 96. Grifols Company Information Table 97. Grifols Business Overview Table 98. Grifols Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Grifols Plasma-derived Factor VIII Product Portfolio Table 100. Grifols Recent Development Table 101. Greencross Company Information Table 102. Greencross Business Overview Table 103. Greencross Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Greencross Plasma-derived Factor VIII Product Portfolio Table 105. Greencross Recent Development Table 106. CSL Company Information Table 107. CSL Business Overview Table 108. CSL Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. CSL Plasma-derived Factor VIII Product Portfolio Table 110. CSL Recent Development Table 111. BPL Company Information Table 112. BPL Business Overview Table 113. BPL Plasma-derived Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. BPL Plasma-derived Factor VIII Product Portfolio Table 115. BPL Recent Development Table 116. North America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 117. North America Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 118. North America Plasma-derived Factor VIII Sales Market Share by Country (2021-2026) Table 119. North America Plasma-derived Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 120. North America Plasma-derived Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 121. North America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Plasma-derived Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Plasma-derived Factor VIII Market Share by Country (2021-2026) Table 124. North America Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Plasma-derived Factor VIII Market Share Forecast by Country (2027-2032) Table 126. Europe Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 127. Europe Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 128. Europe Plasma-derived Factor VIII Sales Market Share by Country (2021-2026) Table 129. Europe Plasma-derived Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 130. Europe Plasma-derived Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Plasma-derived Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Plasma-derived Factor VIII Market Share by Country (2021-2026) Table 134. Europe Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Plasma-derived Factor VIII Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 138. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Plasma-derived Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 140. Asia-Pacific Plasma-derived Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Plasma-derived Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Plasma-derived Factor VIII Market Share by Country (2021-2026) Table 144. Asia-Pacific Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Plasma-derived Factor VIII Market Share Forecast by Country (2027-2032) Table 146. Latin America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 147. Latin America Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 148. Latin America Plasma-derived Factor VIII Sales Market Share by Country (2021-2026) Table 149. Latin America Plasma-derived Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 150. Latin America Plasma-derived Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Plasma-derived Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Plasma-derived Factor VIII Market Share by Country (2021-2026) Table 154. Latin America Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Plasma-derived Factor VIII Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Plasma-derived Factor VIII Sales by Country (2021-2026) & (units) Table 158. Middle East and Africa Plasma-derived Factor VIII Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Plasma-derived Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 160. Middle East and Africa Plasma-derived Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Plasma-derived Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Plasma-derived Factor VIII Market Share by Country (2021-2026) Table 164. Middle East and Africa Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Plasma-derived Factor VIII Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Plasma-derived Factor VIII Distributors List Table 169. Plasma-derived Factor VIII Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Plasma-derived Factor VIII Image Figure 2. Global Plasma-derived Factor VIII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma-derived Factor VIII Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma-derived Factor VIII Sales (2021-2032) & (units) Figure 5. 200IU Image Figure 6. Global 200IU Sales YoY Growth (2021-2032) & (units) Figure 7. 250IU Image Figure 8. Global 250IU Sales YoY Growth (2021-2032) & (units) Figure 9. Global Plasma-derived Factor VIII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Plasma-derived Factor VIII Market Share by Type 2025 VS 2032 Figure 11. North America Plasma-derived Factor VIII Sales Market Share in Volume by Type in 2025 Figure 12. North America Plasma-derived Factor VIII Sales Market Share in Value by Type in 2025 Figure 13. Europe Plasma-derived Factor VIII Sales Market Share in Volume by Type in 2025 Figure 14. Europe Plasma-derived Factor VIII Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Plasma-derived Factor VIII Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Plasma-derived Factor VIII Sales Market Share in Value by Type in 2025 Figure 17. Latin America Plasma-derived Factor VIII Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Plasma-derived Factor VIII Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Plasma-derived Factor VIII Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Plasma-derived Factor VIII Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Plasma-derived Factor VIII Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (units) Figure 27. Global Plasma-derived Factor VIII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Plasma-derived Factor VIII Market Share by Application 2025 VS 2032 Figure 29. North America Plasma-derived Factor VIII Sales Market Share in Volume by Application in 2025 Figure 30. North America Plasma-derived Factor VIII Sales Market Share in Value by Application in 2025 Figure 31. Europe Plasma-derived Factor VIII Sales Market Share in Volume by Application in 2025 Figure 32. Europe Plasma-derived Factor VIII Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Plasma-derived Factor VIII Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Plasma-derived Factor VIII Sales Market Share in Value by Application in 2025 Figure 35. Latin America Plasma-derived Factor VIII Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Plasma-derived Factor VIII Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Plasma-derived Factor VIII Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Plasma-derived Factor VIII Sales Market Share in Value by Application in 2025 Figure 39. North America Plasma-derived Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Plasma-derived Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Plasma-derived Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Plasma-derived Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Plasma-derived Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Plasma-derived Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Plasma-derived Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Plasma-derived Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Plasma-derived Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Plasma-derived Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Plasma-derived Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Plasma-derived Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Plasma-derived Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Plasma-derived Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Plasma-derived Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Plasma-derived Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Plasma-derived Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Plasma-derived Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Plasma-derived Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Plasma-derived Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Plasma-derived Factor VIII Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Plasma-derived Factor VIII Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 250IU
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Takeda
  • RAAS
  • Hualan Bio
  • Octapharma
  • Kedrion
  • Grifols
  • Greencross
  • CSL
  • BPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasma-derived Factor VIII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Plasma-derived Factor VIII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Plasma-derived Factor VIII Market by Type
  6. 1.3.1 200IU
  7. 1.3.2 250IU
  8. 1.4 Global Plasma-derived Factor VIII Market Size by Type
  9. 1.4.1 Global Plasma-derived Factor VIII Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Plasma-derived Factor VIII Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Plasma-derived Factor VIII Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Plasma-derived Factor VIII Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Plasma-derived Factor VIII Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Plasma-derived Factor VIII Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Plasma-derived Factor VIII Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Plasma-derived Factor VIII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Plasma-derived Factor VIII Industry Trends
  2. 2.2 Plasma-derived Factor VIII Industry Drivers
  3. 2.3 Plasma-derived Factor VIII Industry Opportunities and Challenges
  4. 2.4 Plasma-derived Factor VIII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Plasma-derived Factor VIII Revenue (2021-2026)
  2. 3.2 Global Top Players by Plasma-derived Factor VIII Sales (2021-2026)
  3. 3.3 Global Top Players by Plasma-derived Factor VIII Price (2021-2026)
  4. 3.4 Global Plasma-derived Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma-derived Factor VIII Major Company Production Sites & Headquarters
  6. 3.6 Global Plasma-derived Factor VIII Company, Product Type & Application
  7. 3.7 Global Plasma-derived Factor VIII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma-derived Factor VIII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma-derived Factor VIII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma-derived Factor VIII Tier 1, Tier 2, and Tier 3
4 Plasma-derived Factor VIII Regional Status and Outlook
  1. 4.1 Global Plasma-derived Factor VIII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Plasma-derived Factor VIII Historic Market Size by Region
  3. 4.2.1 Global Plasma-derived Factor VIII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Plasma-derived Factor VIII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Plasma-derived Factor VIII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Plasma-derived Factor VIII Forecasted Market Size by Region
  7. 4.3.1 Global Plasma-derived Factor VIII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Plasma-derived Factor VIII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Plasma-derived Factor VIII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasma-derived Factor VIII by Application
  1. 5.1 Plasma-derived Factor VIII Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Plasma-derived Factor VIII Market Size by Application
  5. 5.2.1 Global Plasma-derived Factor VIII Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Plasma-derived Factor VIII Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Plasma-derived Factor VIII Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Plasma-derived Factor VIII Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Plasma-derived Factor VIII Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Plasma-derived Factor VIII Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Plasma-derived Factor VIII Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Plasma-derived Factor VIII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Plasma-derived Factor VIII Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 RAAS
  8. 6.2.1 RAAS Company Information
  9. 6.2.2 RAAS Business Overview
  10. 6.2.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 RAAS Plasma-derived Factor VIII Product Portfolio
  12. 6.2.5 RAAS Recent Developments
  13. 6.3 Hualan Bio
  14. 6.3.1 Hualan Bio Company Information
  15. 6.3.2 Hualan Bio Business Overview
  16. 6.3.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hualan Bio Plasma-derived Factor VIII Product Portfolio
  18. 6.3.5 Hualan Bio Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Plasma-derived Factor VIII Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Plasma-derived Factor VIII Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 Grifols
  32. 6.6.1 Grifols Company Information
  33. 6.6.2 Grifols Business Overview
  34. 6.6.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Grifols Plasma-derived Factor VIII Product Portfolio
  36. 6.6.5 Grifols Recent Developments
  37. 6.7 Greencross
  38. 6.7.1 Greencross Company Information
  39. 6.7.2 Greencross Business Overview
  40. 6.7.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Greencross Plasma-derived Factor VIII Product Portfolio
  42. 6.7.5 Greencross Recent Developments
  43. 6.8 CSL
  44. 6.8.1 CSL Company Information
  45. 6.8.2 CSL Business Overview
  46. 6.8.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSL Plasma-derived Factor VIII Product Portfolio
  48. 6.8.5 CSL Recent Developments
  49. 6.9 BPL
  50. 6.9.1 BPL Company Information
  51. 6.9.2 BPL Business Overview
  52. 6.9.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BPL Plasma-derived Factor VIII Product Portfolio
  54. 6.9.5 BPL Recent Developments
7 North America by Country
  1. 7.1 North America Plasma-derived Factor VIII Sales by Country
  2. 7.1.1 North America Plasma-derived Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Plasma-derived Factor VIII Sales by Country (2021-2026)
  4. 7.1.3 North America Plasma-derived Factor VIII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Plasma-derived Factor VIII Market Size by Country
  6. 7.2.1 North America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Plasma-derived Factor VIII Market Size by Country (2021-2026)
  8. 7.2.3 North America Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Plasma-derived Factor VIII Sales by Country
  2. 8.1.1 Europe Plasma-derived Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Plasma-derived Factor VIII Sales by Country (2021-2026)
  4. 8.1.3 Europe Plasma-derived Factor VIII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Plasma-derived Factor VIII Market Size by Country
  6. 8.2.1 Europe Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Plasma-derived Factor VIII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Plasma-derived Factor VIII Sales by Country
  2. 9.1.1 Asia-Pacific Plasma-derived Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Plasma-derived Factor VIII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Plasma-derived Factor VIII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Plasma-derived Factor VIII Market Size by Country
  6. 9.2.1 Asia-Pacific Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Plasma-derived Factor VIII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Plasma-derived Factor VIII Sales by Country
  2. 10.1.1 South America Plasma-derived Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Plasma-derived Factor VIII Sales by Country (2021-2026)
  4. 10.1.3 South America Plasma-derived Factor VIII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Plasma-derived Factor VIII Market Size by Country
  6. 10.2.1 South America Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Plasma-derived Factor VIII Market Size by Country (2021-2026)
  8. 10.2.3 South America Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Plasma-derived Factor VIII Sales by Country
  2. 11.1.1 Middle East and Africa Plasma-derived Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Plasma-derived Factor VIII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Plasma-derived Factor VIII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Plasma-derived Factor VIII Market Size by Country
  6. 11.2.1 Middle East and Africa Plasma-derived Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Plasma-derived Factor VIII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Plasma-derived Factor VIII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Plasma-derived Factor VIII Value Chain Analysis
  2. 12.1.1 Plasma-derived Factor VIII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Plasma-derived Factor VIII Production Mode & Process
  7. 12.2 Plasma-derived Factor VIII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Plasma-derived Factor VIII Distributors
  10. 12.2.3 Plasma-derived Factor VIII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst